Xiaoling Jiang
VP, Chief Scientific Officer & Executive DirectorMs. Xiaoling Jiang is Vice President and Executive Director of Sunho Biologics, Inc. since July 22, 2023 and was its Joint Chief Scientific Officer & Co-CEO from January 23, 2026 until February 28, 2026 and is its CEO & Chief Scientific Officer from February 28, 2026 and she was appointed as a Director on July 21, 2023. She has joined as a deputy general manager and the head of R&D at SunHo (China) BioPharmaceutical since February 2020. She is responsible for management of R&D department and product registration. Ms. Jiang is also a supervisor of SunHo (China) BioPharmaceutical, Sunho Pharmaceutical Technology and SunHo (Zhejiang) BioPharmaceutical. Ms. Jiang has experience in R&D of pharmaceuticals, including biosimilar drugs and antibody drugs. From December 2007 to October 2009, Ms. Jiang worked as a researcher at Dragon Boat Pharmaceutical Technology (Shanghai) Co., Ltd., a company principally engaged in the R&D of biologics, where she was involved in protein expression-related drugs and cell line construction. From October 2009 to October 2011, she worked as a senior researcher at Nanjing GenScript Biotechnology Co., Ltd., a company principally engaged in providing outsourcing services for the R&D of antibody drugs, where she was primarily responsible for production of stable cell line construction and R&D of biosimilar drugs. From October 2011 to February 2020, she served as a project leader and project manager at Nanjing Yoko Pharma Co., Ltd., a wholly-owned subsidiary of Nanjing Yoko, where she was primarily responsible for R&D of chemical drugs. Ms. Jiang obtained her bachelor’s degree in biotechnology from Shandong Agriculture University in Shandong in July 2005. She further obtained her master’s degree in biochemistry and molecular biology from Nanjing University in Jiangsu in June 2008. She has been certified as an engineer by the Nanjing Professional Titles Working Leading Group since July 2011.
Positions
- Company NameSunho Biologics, Inc.Stock Code02898PositionVP, Chief Scientific Officer & Executive Director
